MS-DRG · FY 2026 v43.0

MS-DRG 267 – Endovascular Cardiac Valve Replacement and Supplement Procedures without MCC

A Surgical DRG in MDC 05 (Diseases & Disorders of the Circulatory System). Inpatient cases group to DRG 267 when one of the 66 ICD-10-PCS operating-room procedures listed below is reported. Its FY 2026 relative weight is 4.7608 with a geometric mean length of stay of 1.3 days.

Surgical DRG – assigned by operating-room procedure✓ Official CMS v43.0 dataset
4.7608
Relative Weight
1.3
Geometric Mean LOS (days)
1.5
Arithmetic Mean LOS (days)
66
Procedure Codes

Severity family

DRG 266with MCCWeight 6.1284 · GMLOS 2.5 daysDRG 267without MCCWeight 4.7608 · GMLOS 1.3 days
How a case is assigned to DRG 267

The grouper first assigns the case to MDC 05 from the principal diagnosis, then matches a qualifying operating-room procedure from the ICD-10-PCS list below (this is a Surgical DRG), then applies the severity split from secondary diagnoses: with MCC → 266; without MCC → 267.

ICD-10-PCS

Procedure Codes 66 codes · 10 categories

66 of 66 shown
02RF Heart and Great Vessels, Replacement9 codes
  • 02RF37H Replacement of Aortic Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RF37Z Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02RF38H Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
  • 02RF38N Replacement of Aortic Valve with Zooplastic Tissue, using Rapid Deployment Technique, Percutaneous Approach
  • 02RF38Z Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach
  • 02RF3JH Replacement of Aortic Valve with Synthetic Substitute, Transapical, Percutaneous Approach
  • 02RF3JZ Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Approach
  • 02RF3KH Replacement of Aortic Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RF3KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02RG Heart and Great Vessels, Replacement8 codes
  • 02RG37H Replacement of Mitral Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RG37Z Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02RG38H Replacement of Mitral Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
  • 02RG38Z Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach
  • 02RG3JH Replacement of Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach
  • 02RG3JZ Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach
  • 02RG3KH Replacement of Mitral Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RG3KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02RH Heart and Great Vessels, Replacement10 codes
  • 02RH37H Replacement of Pulmonary Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RH37Z Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02RH38H Replacement of Pulmonary Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
  • 02RH38L Replacement of Pulmonary Valve with Zooplastic Tissue, In Existing Conduit, Percutaneous Approach
  • 02RH38M Replacement of Pulmonary Valve with Zooplastic Tissue, Native Site, Percutaneous Approach
  • 02RH38Z Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach
  • 02RH3JH Replacement of Pulmonary Valve with Synthetic Substitute, Transapical, Percutaneous Approach
  • 02RH3JZ Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
  • 02RH3KH Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RH3KZ Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02RJ Heart and Great Vessels, Replacement8 codes
  • 02RJ37H Replacement of Tricuspid Valve with Autologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RJ37Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02RJ38H Replacement of Tricuspid Valve with Zooplastic Tissue, Transapical, Percutaneous Approach
  • 02RJ38Z Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach
  • 02RJ3JH Replacement of Tricuspid Valve with Synthetic Substitute, Transapical, Percutaneous Approach
  • 02RJ3JZ Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Approach
  • 02RJ3KH Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Transapical, Percutaneous Approach
  • 02RJ3KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UF Heart and Great Vessels, Supplement8 codes
  • 02UF37J Supplement Aortic Valve created from Truncal Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UF37Z Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UF38J Supplement Aortic Valve created from Truncal Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UF38Z Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UF3JJ Supplement Aortic Valve created from Truncal Valve with Synthetic Substitute, Percutaneous Approach
  • 02UF3JZ Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach
  • 02UF3KJ Supplement Aortic Valve created from Truncal Valve with Nonautologous Tissue Substitute, Percutaneous Approach
  • 02UF3KZ Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UG Heart and Great Vessels, Supplement9 codes
  • 02UG37E Supplement Mitral Valve created from Left Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UG37Z Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UG38E Supplement Mitral Valve created from Left Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UG38Z Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UG3JE Supplement Mitral Valve created from Left Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach
  • 02UG3JH Supplement Mitral Valve with Synthetic Substitute, Transapical, Percutaneous Approach
  • 02UG3JZ Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach
  • 02UG3KE Supplement Mitral Valve created from Left Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach
  • 02UG3KZ Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UH Heart and Great Vessels, Supplement4 codes
  • 02UH37Z Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UH38Z Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UH3JZ Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
  • 02UH3KZ Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UJ Heart and Great Vessels, Supplement8 codes
  • 02UJ37G Supplement Tricuspid Valve created from Right Atrioventricular Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UJ37Z Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach
  • 02UJ38G Supplement Tricuspid Valve created from Right Atrioventricular Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UJ38Z Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach
  • 02UJ3JG Supplement Tricuspid Valve created from Right Atrioventricular Valve with Synthetic Substitute, Percutaneous Approach
  • 02UJ3JZ Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach
  • 02UJ3KG Supplement Tricuspid Valve created from Right Atrioventricular Valve with Nonautologous Tissue Substitute, Percutaneous Approach
  • 02UJ3KZ Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach
X2RJ New Technology, Cardiovascular System, Replacement1 code
  • X2RJ3RA Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10
X2U9 New Technology, Cardiovascular System, Supplement1 code
  • X2U93YA Supplement Right Atrium with Intraluminal Device, Heterotopic Bioprosthetic Valve(s), Percutaneous Approach, New Technology Group 10
ICD-10-CM

Qualifying Diagnosis Codes

Diagnosis codes do not drive assignment for this DRG. Cases group here from the ICD-10-PCS procedure list below.

Frequently Asked Questions

What is MS-DRG 267?

MS-DRG 267 (Endovascular Cardiac Valve Replacement and Supplement Procedures without MCC) is a surgical DRG in MDC 05 (Diseases & Disorders of the Circulatory System). Its FY 2026 relative weight is 4.7608 with a geometric mean length of stay of 1.3 days.

What is the difference between DRG 266, 267?

All 2 share the same base category; the severity of secondary diagnoses separates them: 266 (with MCC), 267 (without MCC). A major complication or comorbidity (MCC) places the case in the highest-weighted DRG of the family; a CC in the middle; neither in the lowest.

How many procedure codes group to DRG 267?

66 ICD-10-PCS operating-room procedure codes group to this DRG.

What is the relative weight of DRG 267?

The FY 2026 relative weight of this DRG is 4.7608, meaning reimbursement of roughly 4.76 times the average Medicare inpatient case. Multiply by a hospital's blended base rate for the approximate payment.

← PreviousDRG 266 – Endovascular Cardiac Valve Replacement and Supplement
Source: CMS ICD-10 MS-DRG v43.0 Definitions Manual and the FY 2026 IPPS Final Rule (Table 5), effective October 1, 2025 through September 30, 2026. We publish the DRG assignments as CMS defines them and add the navigation, search, and code links.